Ignite Creation Date:
2025-12-24 @ 10:42 PM
Ignite Modification Date:
2026-03-06 @ 6:24 PM
Study NCT ID:
NCT02664935
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-05-21
First Post:
2016-01-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer
Sponsor:
University of Birmingham
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
RG_14-072
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None